leridistim

Source:http://linkedlifedata.com/resource/umls/id/C0919350

NCI: A substance that is being studied for its ability to stimulate the production of blood cells during chemotherapy. It belongs to the family of drugs called colony-stimulating factors.,PDQ: A recombinant chimeric dual G-CSF and IL-3 receptor agonist. Leridistim binds with high affinity to both the interleukin-3 (IL-3) and granulocyte colony-stimulating factor (G-CSF) receptors, thereby stimulating the production and maturation of neutrophils, platelets, and lymphocytes after chemotherapy. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=43477&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=43477&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1846" NCI Thesaurus),NCI: A recombinant chimeric dual G-CSF and IL-3 receptor agonist. Leridistim binds with high affinity to both the interleukin-3 (IL-3) and granulocyte colony-stimulating factor (G-C

Download in:

View as